Properties |
Information |
PhytoCAT-ID |
PhytoCAT-851 |
Phytochemical name or plant extracts |
Ailanthone |
PMID |
29552229 |
Literature evidence |
The present study revealed the presence of ailanthone-mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy. |
IUPAC name |
(1S,4R,5R,7S,11R,13S,17S,18S,19R)-4,5,17-trihydroxy-14,18-dimethyl-6-methylidene-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-ene-9,16-dione |
Phytochemicals’ class or type of plant extracts |
Methanolic extract |
Source of phytochemicals or plant Extracts |
Ailanthus altissima |
|
Geographical availability |
China North-Central, China South-Central, China Southeast, Inner Mongolia, Manchuria, Taiwan, Tibet, Xinjiang |
Plant parts |
Bark |
Other cancers |
Breast cancer |
Target gene or protein |
Bax, Bcl-2 |
Gene or Protein evidence |
Western blot analysis was used to detect levels of Bax and Bcl-2 protein expression, it was demonstrated that following treatment of MCF-7 cells with 0.5, 1.0, 2.0, 4.0 or 8.0 µg/ml ailanthone for 48 h, Bax expression increased, whereas that of Bcl-2 decreased markedly. |
Target pathways |
PI3K/AKT pathway |
IC50 |
NA |
Potency |
The present study revealed the presence of ailanthone-mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy. |
Cell line/ mice model |
MCF-7 |
Additional information |
Flow cytometry assay demonstrated that ailanthone induced apoptosis and G0/G1 cell cycle arrest in MCF-7 cells.
Western blotting and RT-PCR assays demonstrated that upregulation of pro-apoptotic caspase-3 and Bcl-associated X, and downregulation of anti-apoptotic apoptosis regulator B-cell lymphoma-2 in MCF-7 cells may be associated with the induction of apoptosis and inhibition of proliferation. |
PubChem ID |
72965 |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:813521-1 |
Safety |
NA |